Investigational Drug Information for Asoprisnil
✉ Email this page to a colleague
What is the development status for investigational drug Asoprisnil?
Asoprisnil is an investigational drug.
There have been 15 clinical trials for Asoprisnil.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2003.
The most common disease conditions in clinical trials are Myofibroma, Leiomyoma, and Menorrhagia. The leading clinical trial sponsors are Abbott, Jenapharm GmbH & Co. KG, and TAP Pharmaceutical Products Inc.
Summary for Asoprisnil
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 416 |
| WIPO Patent Applications | 330 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 3 (2003-09-01) |
| Vendors | 22 |
Recent Clinical Trials for Asoprisnil
| Title | Sponsor | Phase |
|---|---|---|
| Study of Asoprisnil in the Treatment of Uterine Fibroids. | Abbott | Phase 3 |
| Safety of Treatment of Uterine Fibroids With Asoprisnil | Abbott | Phase 3 |
| A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | Abbott | Phase 3 |
Clinical Trial Summary for Asoprisnil
Top disease conditions for Asoprisnil
Top clinical trial sponsors for Asoprisnil
US Patents for Asoprisnil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
